Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study)

Cancer Chemother Pharmacol. 1989:24 Suppl 1:S30. doi: 10.1007/BF00253236.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Clinical Trials as Topic
  • Dactinomycin / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Mesenchymoma / drug therapy*
  • Rhabdomyosarcoma / drug therapy*
  • Vincristine / administration & dosage

Substances

  • Dactinomycin
  • Vincristine
  • Ifosfamide